Company intelligence / Profile preview

Pharmatek Laboratories

San Diego, California, United Statesbiospace.com ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Pharmatek Laboratories specialized in early-phase drug development services including formulation screening, analytical method development, cGMP manufacturing of oral, injectable and topical products. The company supported more than 120 molecules annually for over 100 clients globally before being acquired by Catalent in 2016.

Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Catalent post-acquisition; no major independent partnerships disclosed

Beyond the preview

Go deeper on Pharmatek Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmatek Laboratories.

Explore the full profile